Single Identity Test For Botanicals "Makes Sense" - Israelsen
This article was originally published in The Tan Sheet
Executive Summary
The use of multiple tests to confirm the identity of botanical ingredients is inappropriate, especially for small manufacturers of dietary supplements, Utah Natural Products Alliance Executive Director Loren Israelsen told FDAers at a public meeting on supplement GMPs in Salt Lake City, Utah Sept. 28.
You may also be interested in...
Supplement Manufacturing Practices Survey Proposed By FDA
FDA is proposing to conduct a survey of dietary supplement companies' existing manufacturing practices for use in developing its proposed rule on industry-wide GMP standards, the agency says in an Oct. 6 Federal Register notice.
Supplement Defect Action Levels To Follow GMP Reg - FDAer
The establishment of defect action levels (DALs) for dietary supplement ingredients likely will be handled separately from FDA's pending proposed rule on Good Manufacturing Practice standards for supplements, FDA Consumer Safety Officer Karen Strauss told small business reps at a GMPs meeting in Salt Lake City, Utah Sept. 28.
GMP Identity Test Exemption For Small Ingredient Batches Suggested To FDA
Batches of raw plant materials under 500 lbs. should be exempt from multiple identity tests that would be required under future GMP standards for dietary supplements, American Herbal Products Association rep Beth Lambert said at an FDA meeting in Las Vegas July 12.